These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4863523)

  • 1. [The treatment of exudative diabetic retinopathies with clofibrate (Atromid-S)].
    Houtsmuller AJ
    Ned Tijdschr Geneeskd; 1967 Nov; 111(45):2039-40. PubMed ID: 4863523
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of exudative diabetic retinopathy with atromid-S.
    Houtsmuller AJ
    Ophthalmologica; 1968; 156(1):2-5. PubMed ID: 4876848
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of Atromid therapy in exudative diabetic retinopathy.
    Cullen JF; Ireland JT; Oliver MF
    Trans Ophthalmol Soc U K (1962); 1964; 84():281-95. PubMed ID: 5227423
    [No Abstract]   [Full Text] [Related]  

  • 4. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
    Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 6. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind trial of Atromid-S in exudative diabetic retinopathy.
    Cullen JF; Town SM; Campbell CJ
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):554-62. PubMed ID: 4619857
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of diabetic retinopathy.
    Scott GI; Cullen JF
    Bibl Ophthalmol; 1968; 76():146-53. PubMed ID: 5674835
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of diabetic retinopathy.
    Cullen JF
    Geriatrics; 1968 Jul; 23(7):137-48. PubMed ID: 5661095
    [No Abstract]   [Full Text] [Related]  

  • 10. Present status of clofibrate therapy in ophthalmology.
    Nolan J; Cullen JF
    Br J Ophthalmol; 1969 Jan; 53(1):9-15. PubMed ID: 5775576
    [No Abstract]   [Full Text] [Related]  

  • 11. [The value of lipavlon in diabetic retinopathy].
    François P; Belervacque A; Turut P
    Bull Soc Ophtalmol Fr; 1970 Apr; 70(4):568-73. PubMed ID: 5474598
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Regelan (Atromid-S) on serum lipids and platelet aggregation in occlusive arterial disease].
    Fischer M; Irsigler K
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):248-51. PubMed ID: 4880993
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of thromboangiitis obliterans with clofibrate (Atromid-S).
    Cotton RC; Craven JL
    Angiology; 1968 May; 19(5):307-10. PubMed ID: 5656796
    [No Abstract]   [Full Text] [Related]  

  • 15. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.
    Gloster J; Hartley RE; Perkins ES
    Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 18. A STUDY OF THE EFFECT OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY.
    IRELAND JT; CULLEN JF; OLIVER MF; DUNCAN LJ
    J Atheroscler Res; 1963; 3():701-8. PubMed ID: 14100915
    [No Abstract]   [Full Text] [Related]  

  • 19. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].
    Baranova LV
    Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.